NEW YORK, Nov. 01, 2019 (GLOBE NEWSWIRE) --
If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:
Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com
Highlands Bankshares, Inc. HLND
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Highlands Bankshares, Inc. HLND in connection with the proposed acquisition of the Company by First Community Bankshares, Inc. FCBC. Under the terms of the proposed acquisition, HLND shareholders will receive 0.273 shares of FCBC for each HLND share that they own. If you own HLND shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/highlands-bankshares-inc/
Tennessee Community Bank Holdings, Inc. TNCB
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Tennessee Community Bank Holdings, Inc. TNCB in connection with the proposed acquisition of the Company by Reliant Bancorp, Inc. ("RBNC") RBNC. Under the terms of the proposed acquisition, TNCB shareholders will be entitled to receive $17.13 in cash and 0.769 shares of RBNC for each TNCB share that they hold. If you own TNCB shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://weisslawllp.com/tennessee-community-bank-holdings-inc/
Ra Pharmaceuticals, Inc. RARX
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Ra Pharmaceuticals, Inc. RARX in relation to the proposed acquisition of the Company by UCB S.A. Under the terms of the acquisition agreement, RARX shareholders will receive $48.00 in cash for each RARX share that they own. If you own RARX shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/ra-pharmaceuticals-inc/
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.